ing Phase I and Phase II clinical trials. Other forms of experimental treatment that are being examined in in vitro and Currently, interferon alfa is the only approved treatment animal models include antisense oligonucleotides and supfor chronic hepatitis B virus (HBV) infection. A 3-to 6pressive HB
โฆ LIBER โฆ
Combination therapy for chronic hepatitis B
โ Scribed by RJ Fontana; AS Lok
- Book ID
- 118686597
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 130 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Combination therapy for chronic hepatiti
โ
R J Fontana; A S Lok
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 132 KB
Combination therapy for chronic hepatiti
โ
Solko W Schalm
๐
Article
๐
2003
๐
Elsevier Science
๐
English
โ 87 KB
Combination Therapy for Chronic Hepatiti
โ
Navin Paul; Steven-Huy Han
๐
Article
๐
2011
๐
Current Science Inc.
๐
English
โ 150 KB
Combination therapy for chronic hepatiti
โ
Ira M. Jacobson
๐
Article
๐
2008
๐
Elsevier Science
๐
English
โ 104 KB
Interferon-ฮฑ and zidovudine combination
โ
Harry L. A. Janssen; Luuk Berk; Rudolf A. Heijtink; Fiebo J. W. Ten Kate; Solko
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 630 KB
Interferon-a therapy leads to HBeAg seroconversion in only one third of patients with chronic hepatitis B. In an attempt to increase the seroconversion rate, we investigated the combination of interferon-a and zidovudine in a subset of patients with presumably low response rates for interferon-a mon
Are novel combination therapies needed f
โ
Fabien Zoulim
๐
Article
๐
2012
๐
Elsevier Science
๐
English
โ 521 KB